Skip to content

The agreement between KNN volumetry on 1,5 and 3 Tesla brain MRI.

The agreement between KNN volumetry on 1,5 and 3 Tesla brain MRI. - The agreement between KNN volymetry on 1,5 and 3 Tesla brain MRI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35363
Enrollment
10
Registered
2012-04-05
Start date
2012-07-10
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain volume

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: We will select our subjects from a cohort of patients with Chronic Idiopatic Axonal Perpiheral neuropathy (CIAP). Inclusion criteria: Age 50-80 years, a history of cardiovascular disease, 1 or more of the following cardiovascular risk factors: hypertension, diabetes mellitus, BMI > 29, > 10 packyears.

Exclusion criteria

Exclusion criteria: Not living independently. History of brain disease. Contra-indication for MRI: AICD/ICD (automatic heartdefibrillator), Aneurysm clips in the brain placed before 1986 (AZU) or 1990 (Tilburg), Recent endoscopically placed clips in the intestinal system, Breast (mamma) expander with magnets, Cochleair implants, Metal corpus alienum in the eye, Electrical wires (pacemaker wires, ECG wires), Implanted insulin pump, Heart valve prothesis Braunwald - Cutter, Neurostimulator and Vagal Nerve stimulator, Pacemaker, Piston from 1985-1987, Provox ActiValve voisceprothesis, Zenith AAA stent made by Cook, Swan-Ganz catheter, Dental braces, Hydrocefalus pumps, Markers for proton radiation, Piercings, Protheses of 30cm.

Design outcomes

Primary

MeasureTime frame
The agreement of KNN volumetry applied on 1,5 and 3 Tesla MRI of the same subject.

Secondary

MeasureTime frame
n.a.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)